D. Spencer (Newcastle-upon-Tyne, United Kingdom), F. Versteegh (Waddinxveen, Netherlands)
Helium-oxygen gas mixtures in infants with acute bronchiolitis: results of a phase III double-blind, multicentre RCT M. M. M. Chowdhury, C. Pao, C. Pearson, A. Shah, E. Reus, A. Devlin-Jolliffe, J. Lawton, S. McKenzie, P. Habibi (London, United Kingdom; Adelaide, Australia)
| |
The use of home oxygen therapy for the management of children with acute bronchiolitis: the HiTHOx program G. Hall, M. Verheggen, M. Pestell, S. Peter, C. Shackleton, G. Chaney, A. Martin (Perth, Australia)
| |
The infantile bronchiolitis and subsequent airway obstruction P. Koponen, J. Toikka, M. Helminen, M. Korppi (Tampere, Finland)
| |
The effect of palivizumab prophylaxis on serious early childhood wheezing A. Campbell, K. Anderson, L. Fredrick (Abbott Park, United States Of America)
| |
A pilot randomised controlled study of oxygen delivery via vapotherm in infants with moderately severe acute bronchiolitis N. Archer, H. Cottis, S. Ball, K. Mills, T. Hilliard (Bristol, United Kingdom)
| |
Efficacy of nebulized recombinant human alpha-2b interferon in infants with bronchiolitis S. Gerasimov (Lviv, Ukraine)
| |
The role of human bocavirus and human metapneumovirus in etiology of bronchiolitis in children. Rio de Janeiro Brazil M. D. F. March, C. Sant Anna, S. Ferreira, M. A. Guimaraes, I. Iparraguirre, R. Baroni, C. Martins, M. Duarte, D. Vieira, M. Tura (Rio de Janeiro, Brazil)
| |
Serologically verified human bocavirus pneumonia in children M. Don, M. Söderlund-Venermo, A. Lahtinen, L. Hedman, M. Canciani, K. Hedman, M. Korppi (Udine, Italy; Helsinki, Tampere, Finland)
| |
Risk factors for bronchial asthma in infants after respiratory syncytial virus infection A. Fujitsuka, K. Sugai, Y. Kobayashi, H. Kimura, M. Noda, Y. Kaburagi (Yokohama, Tokyo, Japan)
| |
A549 and monocyte derived dendritic cells (MODCS) Transwell co-culture: respiratory syncytial virus (RSV) infection of the apical and basolateral surfaces K. Ugonna, K. Plant, M. Everard (Sheffield, United Kingdom)
| |
Severity markers in hospitalized infants with respiratory syncytial virus infection S. Vieira, A. Gilio, E. Neves, D. Mtsuura, E. Durigon (São Paulo, Brazil)
| |
Mycoplasma pneumoniae associated with Epstein barr in pediatrics L. Alves Vervloet, M. Tironi Junior, V. E. Vervloet, J. D. Riberio (Vitoria, Campinas, Brazil)
| |
The length of hospitalization in pediatric patients with bronchiolitis V. Vlacha, G. Feketea (Patras, Amaliada, Greece)
| |
Immunological and clinical efficacy of flu vaccination in toddlers A. Zaplatnikov, E. Burtceva, E. Shevchenko, L. Vlasova, G. Mingalimova (Moscow, Russian Federation)
| |
Clinical and virologic features of severe bronchiolitis requiring ventilatory support C. Barbàra, P. Papoff, R. Grossi, A. Pierangeli, R. Cicchetti, C. Scagnolari, M. Manganaro, D. De Angelis, E. Bonci, V. Ferro, G. Antonelli, F. Midulla (Rome, Italy)
| |
Acute bronchiolitis in intants A. Manea, M. Boia, D. Iacob, M. Marc (Timisoara, Romania)
| |
Comparison of intramuscular dexamethasone with fluticasone propionate inhaler in treatment of croup M. Modaresi, J. Faghihinia (Isfahan, Islamic Republic Of Iran)
| |
Clinical and virusological effectiveness study of ultralow doses of antibodies to interferon-gamma in treatment of acute respiratory viral infections and influenza in children A. Zaplatnikov, N. Korovina, E. Burtseva, E. Isaeva, E. Shevchenko, I. Zak (Moscow, Russian Federation)
| |
Croup in hospitalized children during the respiratory tract infections off-peak period O. Maliauka, T. Murugova, L. Zayceva, D. Maliauka (Minsk, Belarus)
| |
Haemoptysis in children – some respiratory causes M. Dilberovska, D. Dacevski, J. Buzarov (Skopje, Fyrom)
| |